摘要:
annalsofoncology.org
core.ac.uk
oxfordjournals.org
oup.com
oupjournals.org参考文章(42)
S. Watanabe, T. Tanaka, T. Takeuchi, H. Takabayashi, Y. Hirayama, Advanced gastric cancer with liver metastases successfully treated with S-1. International Journal of Clinical Oncology. ,vol. 7, pp. 326- 329 ,(2002) , 10.1007/S101470200049
Rajesh Krishna, Lawrence D Mayer, Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. European Journal of Pharmaceutical Sciences. ,vol. 11, pp. 265- 283 ,(2000) , 10.1016/S0928-0987(00)00114-7
A Webb, D Cunningham, J H Scarffe, P Harper, A Norman, J K Joffe, M Hughes, J Mansi, M Findlay, A Hill, J Oates, M Nicolson, T Hickish, M O'Brien, T Iveson, M Watson, C Underhill, A Wardley, M Meehan, Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. Journal of Clinical Oncology. ,vol. 15, pp. 261- 267 ,(1997) , 10.1200/JCO.1997.15.1.261
Udo Vanhoefer, Philippe Rougier, Hansjochen Wilke, Michel P. Ducreux, Angel J. Lacave, Eric Van Cutsem, Manfred Planker, José Guimaraes Dos Santos, Pascal Piedbois, Bernard Paillot, Heinrich Bodenstein, Hans-Jochen Schmoll, Harry Bleiberg, Bernard Nordlinger, Marie-Laure Couvreur, Benoit Baron, Jacques A. Wils, Final Results of a Randomized Phase III Trial of Sequential High-Dose Methotrexate, Fluorouracil, and Doxorubicin Versus Etoposide, Leucovorin, and Fluorouracil Versus Infusional Fluorouracil and Cisplatin in Advanced Gastric Cancer: A Trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group Journal of Clinical Oncology. ,vol. 18, pp. 2648- 2657 ,(2000) , 10.1200/JCO.2000.18.14.2648
G Cocconi, M Bella, S Zironi, R Algeri, F Di Costanzo, V De Lisi, G Luppi, B Mazzocchi, C Rodinò, M Soldani, Fluorouracil, doxorubicin, and mitomycin combination versus PELF chemotherapy in advanced gastric cancer: a prospective randomized trial of the Italian Oncology Group for Clinical Research. Journal of Clinical Oncology. ,vol. 12, pp. 2687- 2693 ,(1994) , 10.1200/JCO.1994.12.12.2687
P Preusser, H Wilke, W Achterrath, U Fink, L Lenaz, A Heinicke, J Meyer, H J Meyer, H Buente, Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer. Journal of Clinical Oncology. ,vol. 7, pp. 1310- 1317 ,(1989) , 10.1200/JCO.1989.7.9.1310
D Kelsen, O T Atiq, L Saltz, D Niedzwiecki, D Ginn, D Chapman, R Heelan, C Lightdale, V Vinciguerra, M Brennan, FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer. Journal of Clinical Oncology. ,vol. 10, pp. 541- 548 ,(1992) , 10.1200/JCO.1992.10.4.541
J A Wils, H O Klein, D J Wagener, H Bleiberg, H Reis, F Korsten, T Conroy, M Fickers, S Leyvraz, M Buyse, Sequential high-dose methotrexate and fluorouracil combined with doxorubicin: A step ahead in the treatment of advanced gastric cancer: a trial of the European organization for research and treatment of cancer gastrointestinal tract cooperative group Journal of Clinical Oncology. ,vol. 9, pp. 827- 831 ,(1991) , 10.1200/JCO.1991.9.5.827
Aris Bamias, Mark E. Hill, David Cunningham, Andrew R. Norman, Fareeda Y. Ahmed, Andrew Webb, Maggie Watson, Andrea S. Hill, Marianne C. Nicolson, Mary E. O'Brien, T. Christopher Evans, Viola Nicolson, Epirubicin, Cisplatin, and Protracted Venous Infusion of 5-Fluorouracil for Esophagogastric Adenocarcinoma Response, Toxicity, Quality of Life, and Survival Cancer. ,vol. 77, pp. 1978- 1985 ,(1996) , 10.1002/(SICI)1097-0142(19960515)77:10<1978::AID-CNCR3>3.0.CO;2-D
M. Ychou, C. Astre, Ph. Rouanet, J.M. Fahbre, B. Saint-Aubert, J. Domergue, D. Ribard, A.J. Ciurana, Ch. Janbon, H. Pujol, A Phase II study of 5-fluorouracil, leucovorin and cisplatin (FLP) for metastatic gastric cancer European Journal of Cancer. ,vol. 32, pp. 1933- 1937 ,(1996) , 10.1016/0959-8049(96)00147-5